It's a good company with specialised products that is used by a number of big players. The biggest risk is the top 5 clients account for majority of the revenue.
Contract loss for one of those clients could see the revenue dipped 20% or so.. Given there are a lot of better IPOs that are coming up, I'll probably give this a miss.
The demand isn't that much either..
